Global Hepatitis A Vaccine Market Report (2026–2036)
Market Overview
The global Hepatitis A Vaccine market is projected to grow steadily between 2026 and 2036, driven by increasing awareness of preventive healthcare, rising vaccination programs in emerging economies, and government initiatives to reduce the burden of infectious diseases. The market is expected to expand at a significant CAGR during the forecast period, supported by technological advancements in vaccine production and distribution.
Key Players
- GlaxoSmithKline plc (GSK)
- Merck Sharp & Dohme Corp. (MSD)
- Sanofi Pasteur S.A.
- Novartis AG
- Crucell Switzerland AG (Berna+Crucell)
- China Academy of Medical Sciences
- Changchun Institute of Biological Products
- Zhejiang Pukang
- ChangSheng
- Sinovac Biotech Ltd.
- Shanghai Zerun Biotechnology
- Pfizer Inc.
- Bharat Biotech
- Serum Institute of India Pvt. Ltd.
- Emergent BioSolutions Inc.
- CSL Limited (Seqirus)
Segments Analysis
By Product Type
- Inactivated Hepatitis A Vaccine
- Live Attenuated Hepatitis A Vaccine
- Combination Vaccines (Hepatitis A + Hepatitis B, Hepatitis A + Typhoid)
- Next-generation recombinant vaccines
By Application
- Hospitals
- Other Medical Institutions (clinics, vaccination centers)
- Public Health Programs
- Travel Clinics (for international travelers)
Regional Analysis
- North America: United States, Canada, Mexico
- Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
- Asia-Pacific: China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific
- Central & South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: Saudi Arabia, Turkey, Rest of MEA
Porter’s Five Forces
- Threat of New Entrants – Low; high R&D costs and regulatory barriers limit entry.
- Bargaining Power of Suppliers – Moderate; specialized raw materials and biotechnological expertise are required.
- Bargaining Power of Buyers – High; governments and NGOs demand affordable vaccines for mass immunization.
- Threat of Substitutes – Low; limited alternatives to vaccination for Hepatitis A prevention.
- Industry Rivalry – High; competition among global and regional vaccine manufacturers.
SWOT Analysis
Strengths
- Strong global demand for preventive vaccines
- Established players with robust distribution networks
- Government-backed immunization programs
Weaknesses
- High production costs and cold-chain requirements
- Limited awareness in certain developing regions
Opportunities
- Expansion into emerging markets with rising healthcare investments
- Development of combination vaccines for broader protection
- Increasing travel-related vaccination demand
Threats
- Stringent regulatory approvals and compliance requirements
- Competition from established vaccines and generics
- Risk of supply chain disruptions
Trend Analysis
- Rising adoption of combination vaccines for convenience and broader coverage
- Increasing focus on public-private partnerships for vaccination programs
- Expansion of travel-related vaccination services
- Growing demand for affordable vaccines in emerging economies
- Technological advancements in cold-chain logistics and distribution
Drivers & Challenges
Drivers
- Rising incidence of Hepatitis A in developing countries
- Increasing government initiatives for mass immunization
- Growing awareness of preventive healthcare and travel-related risks
Challenges
- High R&D and production costs
- Cold-chain logistics and distribution challenges
- Regulatory hurdles across multiple regions
Value Chain Analysis
- Upstream: Raw material suppliers (biological reagents, cell lines, adjuvants)
- Midstream: Vaccine manufacturers, biotech firms, research institutions
- Downstream: Hospitals, clinics, vaccination centers, NGOs
- End Users: Children, travelers, and populations in endemic regions
Quick Recommendations for Stakeholders
- Manufacturers: Invest in combination vaccines and expand production capacity in emerging markets.
- Investors: Focus on companies with strong pipelines and government partnerships.
- Healthcare Providers: Strengthen awareness campaigns and vaccination outreach programs.
- Policy Makers: Support funding for immunization programs and improve cold-chain infrastructure.
- Distributors: Expand into Asia-Pacific and Latin America to capture high-growth demand.
Table of Contents
Global Hepatitis A Vaccine Sales Market Report 2018
1 Hepatitis A Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Classification of Hepatitis A Vaccine by Product Category
1.2.1 Global Hepatitis A Vaccine Market Size (Sales) Comparison by Type
1.2.2 Global Hepatitis A Vaccine Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 Liver Inactivated Vaccine
1.2.4 Live Attenuated Vaccine
1.3 Global Hepatitis A Vaccine Market by Application/End Users
1.3.1 Global Hepatitis A Vaccine Sales (Volume) and Market Share Comparison by Application
1.3.1 Hospitals
1.3.2 Other Medical Institutions
1.4 Global Hepatitis A Vaccine Market by Region
1.4.1 Global Hepatitis A Vaccine Market Size (Value) Comparison by Region
1.4.2 United States Hepatitis A Vaccine Status and Prospect
1.4.3 Europe Hepatitis A Vaccine Status and Prospect
1.4.4 China Hepatitis A Vaccine Status and Prospect
1.4.5 Japan Hepatitis A Vaccine Status and Prospect
1.4.6 Southeast Asia Hepatitis A Vaccine Status and Prospect
1.4.7 India Hepatitis A Vaccine Status and Prospect
1.5 Global Market Size (Value and Volume) of Hepatitis A Vaccine
1.5.1 Global Hepatitis A Vaccine Sales and Growth Rate
1.5.2 Global Hepatitis A Vaccine Revenue and Growth Rate
2 Global Hepatitis A Vaccine Competition by Players/Suppliers, Type and Application
2.1 Global Hepatitis A Vaccine Market Competition by Players/Suppliers
2.1.1 Global Hepatitis A Vaccine Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Hepatitis A Vaccine Revenue and Share by Players/Suppliers ()
2.2 Global Hepatitis A Vaccine (Volume and Value) by Type
2.2.1 Global Hepatitis A Vaccine Sales and Market Share by Type ()
2.2.2 Global Hepatitis A Vaccine Revenue and Market Share by Type ()
2.3 Global Hepatitis A Vaccine (Volume and Value) by Region
2.3.1 Global Hepatitis A Vaccine Sales and Market Share by Region ()
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Region ()
2.4 Global Hepatitis A Vaccine (Volume) by Application
3 United States Hepatitis A Vaccine (Volume, Value and Sales Price)
3.1 United States Hepatitis A Vaccine Sales and Value ()
3.1.1 United States Hepatitis A Vaccine Sales and Growth Rate ()
3.1.2 United States Hepatitis A Vaccine Revenue and Growth Rate ()
3.1.3 United States Hepatitis A Vaccine Sales Price Trend ()
3.2 United States Hepatitis A Vaccine Sales Volume and Market Share by Players ()
3.3 United States Hepatitis A Vaccine Sales Volume and Market Share by Type ()
3.4 United States Hepatitis A Vaccine Sales Volume and Market Share by Application ()
4 Europe Hepatitis A Vaccine (Volume, Value and Sales Price)
4.1 Europe Hepatitis A Vaccine Sales and Value ()
4.1.1 Europe Hepatitis A Vaccine Sales and Growth Rate ()
4.1.2 Europe Hepatitis A Vaccine Revenue and Growth Rate ()
4.1.3 Europe Hepatitis A Vaccine Sales Price Trend ()
4.2 Europe Hepatitis A Vaccine Sales Volume and Market Share by Players ()
4.3 Europe Hepatitis A Vaccine Sales Volume and Market Share by Type ()
4.4 Europe Hepatitis A Vaccine Sales Volume and Market Share by Application ()
5 China Hepatitis A Vaccine (Volume, Value and Sales Price)
5.1 China Hepatitis A Vaccine Sales and Value ()
5.1.1 China Hepatitis A Vaccine Sales and Growth Rate ()
5.1.2 China Hepatitis A Vaccine Revenue and Growth Rate ()
5.1.3 China Hepatitis A Vaccine Sales Price Trend ()
5.2 China Hepatitis A Vaccine Sales Volume and Market Share by Players ()
5.3 China Hepatitis A Vaccine Sales Volume and Market Share by Type ()
5.4 China Hepatitis A Vaccine Sales Volume and Market Share by Application ()
6 Japan Hepatitis A Vaccine (Volume, Value and Sales Price)
6.1 Japan Hepatitis A Vaccine Sales and Value ()
6.1.1 Japan Hepatitis A Vaccine Sales and Growth Rate ()
6.1.2 Japan Hepatitis A Vaccine Revenue and Growth Rate ()
6.1.3 Japan Hepatitis A Vaccine Sales Price Trend ()
6.2 Japan Hepatitis A Vaccine Sales Volume and Market Share by Players ()
6.3 Japan Hepatitis A Vaccine Sales Volume and Market Share by Type ()
6.4 Japan Hepatitis A Vaccine Sales Volume and Market Share by Application ()
7 Southeast Asia Hepatitis A Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Hepatitis A Vaccine Sales and Value ()
7.1.1 Southeast Asia Hepatitis A Vaccine Sales and Growth Rate ()
7.1.2 Southeast Asia Hepatitis A Vaccine Revenue and Growth Rate ()
7.1.3 Southeast Asia Hepatitis A Vaccine Sales Price Trend ()
7.2 Southeast Asia Hepatitis A Vaccine Sales Volume and Market Share by Players ()
7.3 Southeast Asia Hepatitis A Vaccine Sales Volume and Market Share by Type ()
7.4 Southeast Asia Hepatitis A Vaccine Sales Volume and Market Share by Application ()
8 India Hepatitis A Vaccine (Volume, Value and Sales Price)
8.1 India Hepatitis A Vaccine Sales and Value ()
8.1.1 India Hepatitis A Vaccine Sales and Growth Rate ()
8.1.2 India Hepatitis A Vaccine Revenue and Growth Rate ()
8.1.3 India Hepatitis A Vaccine Sales Price Trend ()
8.2 India Hepatitis A Vaccine Sales Volume and Market Share by Players ()
8.3 India Hepatitis A Vaccine Sales Volume and Market Share by Type ()
8.4 India Hepatitis A Vaccine Sales Volume and Market Share by Application ()
9 Global Hepatitis A Vaccine Players/Suppliers Profiles and Sales Data
9.1 GlaxoSmithKline
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Hepatitis A Vaccine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Merck Sharp & Dohme Corp
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Hepatitis A Vaccine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 SANOFI PASTEUR S.A
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Hepatitis A Vaccine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 SANOFI PASTEUR S.A Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 Norvatis
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Hepatitis A Vaccine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Norvatis Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Crucell Switzerland AG(Berna+Crucell)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Hepatitis A Vaccine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
9.6 China Academy of Medical Sciences
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Hepatitis A Vaccine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 China Academy of Medical Sciences Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.6.4 Main Business/Business Overview
9.7 Changchun Institute of Biological Products
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Hepatitis A Vaccine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Changchun Institute of Biological Products Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.7.4 Main Business/Business Overview
9.8 Zhejiang Pukang
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Hepatitis A Vaccine Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.8.4 Main Business/Business Overview
9.9 ChangSheng
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Hepatitis A Vaccine Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.9.4 Main Business/Business Overview
9.10 Sinovac
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Hepatitis A Vaccine Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin ()
9.10.4 Main Business/Business Overview
9.11 Shanghai Zerun Biotechnology
10 Hepatitis A Vaccine Maufacturing Cost Analysis
10.1 Hepatitis A Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A Vaccine
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Hepatitis A Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Hepatitis A Vaccine Market Forecast (2018-2025)
14.1 Global Hepatitis A Vaccine Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Hepatitis A Vaccine Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Hepatitis A Vaccine Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Hepatitis A Vaccine Price and Trend Forecast (2018-2025)
14.2 Global Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Hepatitis A Vaccine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Hepatitis A Vaccine Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Hepatitis A Vaccine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Hepatitis A Vaccine Sales Forecast by Type (2018-2025)
14.3.2 Global Hepatitis A Vaccine Revenue Forecast by Type (2018-2025)
14.3.3 Global Hepatitis A Vaccine Price Forecast by Type (2018-2025)
14.4 Global Hepatitis A Vaccine Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Hepatitis A Vaccine
Figure Global Hepatitis A Vaccine Sales Volume Comparison (K Units) by Type
Figure Global Hepatitis A Vaccine Sales Volume Market Share by Type (Product Category) in
Figure Liver Inactivated Vaccine Product Picture
Figure Live Attenuated Vaccine Product Picture
Figure Global Hepatitis A Vaccine Sales Comparison (K Units) by Application
Figure Global Sales Market Share of Hepatitis A Vaccine by Application in
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Medical Institutions Examples
Table Key Downstream Customer in Other Medical Institutions
Figure Global Hepatitis A Vaccine Market Size (Million USD) by Regions
Figure United States Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure Europe Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure China Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure Japan Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure Southeast Asia Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure India Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure Global Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate
Figure Global Hepatitis A Vaccine Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Hepatitis A Vaccine Sales Volume (K Units) ()
Table Global Hepatitis A Vaccine Sales (K Units) of Key Players/Suppliers ()
Table Global Hepatitis A Vaccine Sales Share by Players/Suppliers ()
Figure Hepatitis A Vaccine Sales Share by Players/Suppliers
Figure Hepatitis A Vaccine Sales Share by Players/Suppliers
Figure Global Hepatitis A Vaccine Revenue (Million USD) by Players/Suppliers ()
Table Global Hepatitis A Vaccine Revenue (Million USD) by Players/Suppliers ()
Table Global Hepatitis A Vaccine Revenue Share by Players/Suppliers ()
Table Global Hepatitis A Vaccine Revenue Share by Players
Table Global Hepatitis A Vaccine Revenue Share by Players
Table Global Hepatitis A Vaccine Sales (K Units) and Market Share by Type ()
Table Global Hepatitis A Vaccine Sales Share (K Units) by Type ()
Figure Sales Market Share of Hepatitis A Vaccine by Type ()
Figure Global Hepatitis A Vaccine Sales Growth Rate by Type ()
Table Global Hepatitis A Vaccine Revenue (Million USD) and Market Share by Type ()
Table Global Hepatitis A Vaccine Revenue Share by Type ()
Figure Revenue Market Share of Hepatitis A Vaccine by Type ()
Figure Global Hepatitis A Vaccine Revenue Growth Rate by Type ()
Table Global Hepatitis A Vaccine Sales Volume (K Units) and Market Share by Region ()
Table Global Hepatitis A Vaccine Sales Share by Region ()
Figure Sales Market Share of Hepatitis A Vaccine by Region ()
Figure Global Hepatitis A Vaccine Sales Growth Rate by Region in
Table Global Hepatitis A Vaccine Revenue (Million USD) and Market Share by Region ()
Table Global Hepatitis A Vaccine Revenue Share (%) by Region ()
Figure Revenue Market Share of Hepatitis A Vaccine by Region ()
Figure Global Hepatitis A Vaccine Revenue Growth Rate by Region in
Table Global Hepatitis A Vaccine Revenue (Million USD) and Market Share by Region ()
Table Global Hepatitis A Vaccine Revenue Share (%) by Region ()
Figure Revenue Market Share of Hepatitis A Vaccine by Region ()
Figure Global Hepatitis A Vaccine Revenue Market Share by Region in
Table Global Hepatitis A Vaccine Sales Volume (K Units) and Market Share by Application ()
Table Global Hepatitis A Vaccine Sales Share (%) by Application ()
Figure Sales Market Share of Hepatitis A Vaccine by Application ()
Figure Global Hepatitis A Vaccine Sales Market Share by Application ()
Figure United States Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure United States Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure United States Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table United States Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table United States Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure United States Hepatitis A Vaccine Sales Volume Market Share by Players in
Table United States Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table United States Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure United States Hepatitis A Vaccine Sales Volume Market Share by Type in
Table United States Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table United States Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure United States Hepatitis A Vaccine Sales Volume Market Share by Application in
Figure Europe Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure Europe Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure Europe Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table Europe Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table Europe Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure Europe Hepatitis A Vaccine Sales Volume Market Share by Players in
Table Europe Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table Europe Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure Europe Hepatitis A Vaccine Sales Volume Market Share by Type in
Table Europe Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table Europe Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure Europe Hepatitis A Vaccine Sales Volume Market Share by Application in
Figure China Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure China Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure China Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table China Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table China Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure China Hepatitis A Vaccine Sales Volume Market Share by Players in
Table China Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table China Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure China Hepatitis A Vaccine Sales Volume Market Share by Type in
Table China Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table China Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure China Hepatitis A Vaccine Sales Volume Market Share by Application in
Figure Japan Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure Japan Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure Japan Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table Japan Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table Japan Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure Japan Hepatitis A Vaccine Sales Volume Market Share by Players in
Table Japan Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table Japan Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure Japan Hepatitis A Vaccine Sales Volume Market Share by Type in
Table Japan Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table Japan Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure Japan Hepatitis A Vaccine Sales Volume Market Share by Application in
Figure Southeast Asia Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure Southeast Asia Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table Southeast Asia Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Players in
Table Southeast Asia Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Type in
Table Southeast Asia Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure Southeast Asia Hepatitis A Vaccine Sales Volume Market Share by Application in
Figure India Hepatitis A Vaccine Sales (K Units) and Growth Rate ()
Figure India Hepatitis A Vaccine Revenue (Million USD) and Growth Rate ()
Figure India Hepatitis A Vaccine Sales Price (USD/Unit) Trend ()
Table India Hepatitis A Vaccine Sales Volume (K Units) by Players ()
Table India Hepatitis A Vaccine Sales Volume Market Share by Players ()
Figure India Hepatitis A Vaccine Sales Volume Market Share by Players in
Table India Hepatitis A Vaccine Sales Volume (K Units) by Type ()
Table India Hepatitis A Vaccine Sales Volume Market Share by Type ()
Figure India Hepatitis A Vaccine Sales Volume Market Share by Type in
Table India Hepatitis A Vaccine Sales Volume (K Units) by Application ()
Table India Hepatitis A Vaccine Sales Volume Market Share by Application ()
Figure India Hepatitis A Vaccine Sales Volume Market Share by Application in
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Growth Rate ()
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Global Market Share ()
Figure GlaxoSmithKline Hepatitis A Vaccine Revenue Global Market Share ()
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales Growth Rate ()
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales Global Market Share ()
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Revenue Global Market Share ()
Table SANOFI PASTEUR S.A Basic Information List
Table SANOFI PASTEUR S.A Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Sales Growth Rate ()
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Sales Global Market Share (
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Revenue Global Market Share ()
Table Norvatis Basic Information List
Table Norvatis Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Norvatis Hepatitis A Vaccine Sales Growth Rate ()
Figure Norvatis Hepatitis A Vaccine Sales Global Market Share ()
Figure Norvatis Hepatitis A Vaccine Revenue Global Market Share ()
Table Crucell Switzerland AG(Berna+Crucell) Basic Information List
Table Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales Growth Rate ()
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales Global Market Share ()
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Revenue Global Market Share ()
Table China Academy of Medical Sciences Basic Information List
Table China Academy of Medical Sciences Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure China Academy of Medical Sciences Hepatitis A Vaccine Sales Growth Rate ()
Figure China Academy of Medical Sciences Hepatitis A Vaccine Sales Global Market Share (
Figure China Academy of Medical Sciences Hepatitis A Vaccine Revenue Global Market Share ()
Table Changchun Institute of Biological Products Basic Information List
Table Changchun Institute of Biological Products Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Sales Growth Rate ()
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Sales Global Market Share ()
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Revenue Global Market Share ()
Table Zhejiang Pukang Basic Information List
Table Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Zhejiang Pukang Hepatitis A Vaccine Sales Growth Rate ()
Figure Zhejiang Pukang Hepatitis A Vaccine Sales Global Market Share (
Figure Zhejiang Pukang Hepatitis A Vaccine Revenue Global Market Share ()
Table ChangSheng Basic Information List
Table ChangSheng Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure ChangSheng Hepatitis A Vaccine Sales Growth Rate ()
Figure ChangSheng Hepatitis A Vaccine Sales Global Market Share ()
Figure ChangSheng Hepatitis A Vaccine Revenue Global Market Share ()
Table Sinovac Basic Information List
Table Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Sinovac Hepatitis A Vaccine Sales Growth Rate ()
Figure Sinovac Hepatitis A Vaccine Sales Global Market Share ()
Figure Sinovac Hepatitis A Vaccine Revenue Global Market Share ()
Table Shanghai Zerun Biotechnology Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis A Vaccine
Figure Manufacturing Process Analysis of Hepatitis A Vaccine
Figure Hepatitis A Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis A Vaccine Major Players in
Table Major Buyers of Hepatitis A Vaccine
Table Distributors/Traders List
Figure Global Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Hepatitis A Vaccine Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Hepatitis A Vaccine Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Hepatitis A Vaccine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Hepatitis A Vaccine Sales Volume Market Share Forecast by Regions in 2025
Table Global Hepatitis A Vaccine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Hepatitis A Vaccine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Hepatitis A Vaccine Revenue Market Share Forecast by Regions in 2025
Figure United States Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Hepatitis A Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure China Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Hepatitis A Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure Global Hepatitis A Vaccine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Hepatitis A Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Global Hepatitis A Vaccine Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Hepatitis A Vaccine Sales (K Units) Forecast by Application (2018-2025)
Figure Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
T
Key Players
- GlaxoSmithKline plc (GSK)
- Merck Sharp & Dohme Corp. (MSD)
- Sanofi Pasteur S.A.
- Novartis AG
- Crucell Switzerland AG (Berna+Crucell)
- China Academy of Medical Sciences
- Changchun Institute of Biological Products
- Zhejiang Pukang
- ChangSheng
- Sinovac Biotech Ltd.
- Shanghai Zerun Biotechnology
- Pfizer Inc.
- Bharat Biotech
- Serum Institute of India Pvt. Ltd.
- Emergent BioSolutions Inc.
- CSL Limited (Seqirus)
Segments Analysis
By Product Type
- Inactivated Hepatitis A Vaccine
- Live Attenuated Hepatitis A Vaccine
- Combination Vaccines (Hepatitis A + Hepatitis B, Hepatitis A + Typhoid)
- Next-generation recombinant vaccines
By Application
- Hospitals
- Other Medical Institutions (clinics, vaccination centers)
- Public Health Programs
- Travel Clinics (for international travelers)
Regional Analysis
- North America: United States, Canada, Mexico
- Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
- Asia-Pacific: China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific
- Central & South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: Saudi Arabia, Turkey, Rest of MEA